Tag: Jonathan Parr

(Following is a look back at the 3rd Annual Global Health Scholars Symposium. Links to recordings are provided throughout.)   Myron Cohen, MD, director of the Institute for Global Health and Infectious Diseases welcomed faculty, students and fellows to the 3rd Annual Global Health Scholars Symposium Friday, Feb. 14, recognizing...

The Office of Fellowships and Training at the UNC Institute for Global Health and Infectious Diseases ensures educational and mentored research training and field experience for eligible masters, doctoral or post-doctoral candidates. Managed by Kristin Reed, MPH; Marla Allen, MPH; Dzidzai Muyengwa, MPH; and Benjamin Chi, MD, MSc, following is...

Syphilis vaccine development remains a high priority with a rising number of congenital syphilis cases worldwide. Unfortunately, vaccine development is still in a pre-clinical phase, and ongoing translational work is needed to identify vaccine candidates targeting highly conserved surface-exposed antigens expressed by geographically diverse strains of Treponema pallidum (TPA). But...

With data from one of the most extensive genomic surveys of the syphilis bacterium – correlated with clinical information from patients – an international team of researchers and doctors are on the hunt for proteins on the surface of the microbe that don’t vary and could be good targets for...

April is sexually transmitted infections (STI) awareness month, and Arlene Seña, MD, MPH, a researcher with the Institute for Global Health and Infectious Diseases, is sounding the alarm about the importance of syphilis prevention, testing, and treatment. U.S. syphilis cases have increased nearly 80% since 2018,  a level not seen...

As the World Health Organization pushes to eradicate the Hepatitis B virus (HBV) by 2030, preventing vertical transmission is key, says Peyton Thompson, MD, MSCR, Assistant Professor of Pediatric Infectious Diseases. But despite widespread availability of effective childhood vaccines, HBV remains endemic throughout sub-Saharan Africa, including the Democratic Republic of the...

Jonathan Parr, MD, MPH, assistant professor medicine and researcher with the Institute for Global Health and Infectious Diseases, has been elected to the American Society for Clinical Investigation (ASCI), a nonprofit medical honor society that seeks to seeks to support the scientific efforts, educational needs, and clinical aspirations of physician-scientists...

Nurturing future global health leaders is crucial to building resilient and sustainable health systems. The Office of Fellowship and Training Programs provides robust clinical and non-clinical experiences for professional and personal growth, led by Benjamin Chi, MD, MSc, the Institute’s Associate Director of Fellowship Programs. “Mentorship and training are pivotal parts...

Post-doctoral fellow Ashenafi Assefa, PhD, and Jonathan Parr, MD, MPH, assistant professor of medicine in infectious diseases, researchers with the Institute for Global Health and Infectious Diseases (IGHID) working in the IDEEL (the Infectious Disease Epidemiology and Ecology) Lab assess the pros and cons of a new strategy to simplify malaria...

Researchers in the Infectious Disease Epidemiology and Ecology Lab (IDEEL) at UNC are process driven investigators with a unique comradery, working in 20+ countries to improve basic understandings of pathogens. The applied nature of their work has a direct impact on the health and well-being of millions of individuals around...

Researchers with the Institute for Global Health and Infectious Diseases (IGHID) through IDEEL (the Infectious Disease Epidemiology and Ecology Lab), have detected new strains of malaria-causing parasites in Ethiopia that are both resistant to current treatments and escape detection by common diagnostic tests. Jonathan Parr, MD, MPH, IGHID member and...

It’s a rare day when an infectious disease story is not in the news–particularly since COVID-19 turned the world upside down and showed the vulnerability of the human condition to emerging pathogens. The field of infectious diseases is dynamic, often characterized by innovation and heroism.   Christopher Sellers, MD, MPH...

Led by Jonathan Parr, MD, MPH, with Jon Juliano, MD, MSPH, and researchers in the Infectious Disease Epidemiology and Ecology Lab (IDEEL), the UNC Institute for Global Health and Infectious Diseases has been awarded a $3.6 million NIH R01 grant to study the rise of drug-resistant malaria in Ethiopia, with partners...

UNC School of Medicine’s Institute for Global Health & Infectious Diseases has been awarded a $2.9 million grant from the Bill & Melinda Gates Foundation to establish malaria genomic surveillance capacity in the Democratic Republic of Congo (DRC).  Dr. Jonathan Parr is the lead PI, with Dr. Jon Juliano and...

Jonathan Parr, MD, MPH, a founding member of the UNC Infectious Disease Epidemiology and Ecology Lab (IDEEL) with the Institute for Global Health & Infectious Diseases is conducting studies in Kinshasa, the capital of the Democratic Republic of the Congo (DRC), to understand the changing prevalence of drug resistance to malaria. Malaria...

Jonathan Juliano, MD, MPSH, Professor of Infectious Diseases and Associate Director of the Institute for Global Health and Infectious Diseases, with fellow IDEEL investigators Jessica Lin, MD, MSCR, and Jonathan Parr, MD, MPH, and co-PIs from the University of Florida (UF) and Centre Pasteur Cameroon, has received a $3.4 million...

During April, STD Awareness provides an opportunity to talk about STIs and encourage individuals to be proactive about their sexual health and promotes regular STI/HIV screening and testing. Although research in sexually transmitted infections (STIs) has evolved rapidly on multiple fronts, a critical remaining challenge is the development of safe and effective...

Michael Sciaudone, MD, an infectious diseases specialist at UNC, has won a 2021 postdoctoral fellowship in tropical infectious diseases from the Burroughs Wellcome Fund-American Society of Tropical Medicine & Hygiene (ASTMH). Three of the coveted fellowships are awarded nationally each year, funding research focused on low and low-middle income countries....

Hepatitis B virus (HBV) remains endemic throughout sub-Saharan Africa despite the widespread availability of effective childhood vaccines. In the Democratic Republic of the Congo, HBV treatment and birth-dose vaccination programs are not established. UNC School of Medicine researchers led a study to evaluate the feasibility and acceptability of HBV testing...

The year was 1993. Alexis Mwanza, then 17, found himself huddled on top of a train, fleeing violence in his home town in the Democratic Republic of Congo by leading nine of his family members 500 miles away to Mbuji Mayi. As a displaced refugee in that city, Mwanza watched...